title: Different effects of oral and transdermal estrogen replacement therapy on matrix metalloproteinase and their inhibitor in postmenopausal women.
authors.forename: Akihiko
authors.initials: A
authors.lastname: Wakatsuki
authors.forename: Nobuo
authors.initials: N
authors.lastname: Ikenoue
authors.forename: Koichi
authors.initials: K
authors.lastname: Shinohara
authors.forename: Kazushi
authors.initials: K
authors.lastname: Watanabe
authors.forename: Takao
authors.initials: T
authors.lastname: Fukaya
mesh_terms: D000279:Administration, Cutaneous; D000284:Administration, Oral; D004958:Estradiol / Q000494:pharmacology*; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000494:pharmacology*; D005260:Female; D006801:Humans; D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases / Q000097:blood / Q000187:drug effects*; D017698:Postmenopause; D019714:Tissue Inhibitor of Metalloproteinases / Q000097:blood / Q000187:drug effects*
chemical_list: D004966:Estrogens, Conjugated (USP); D061965:Matrix Metalloproteinase Inhibitors; D019714:Tissue Inhibitor of Metalloproteinases; D004958:Estradiol; D020782:Matrix Metalloproteinases